Quarterly Transactions Made in Aeglea Bio Therapeutics, Inc. (AGLE)
This table provides information about the institutional ownership of Aeglea Bio Therapeutics, Inc. (AGLE). The information is specifically focused on institutions that hold shares of Aeglea BioTherapeutics, Inc..
Shares Purchased
Shares Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q1 2021 | 1,161,533 | 657,309 | 1,818,842 | 2,489,674 | 136,307 | 2,625,981 | -807,139 | |
| Q2 2021 | 2,098,806 | 5,289,372 | 7,388,178 | 2,076,866 | 320,029 | 2,396,895 | 4,991,283 | |
| Q3 2021 | 885,839 | 4,622,920 | 5,508,759 | 883,900 | 1,165,826 | 2,049,726 | 3,459,033 | |
| Q4 2021 | 3,382,522 | 763,468 | 4,145,990 | 4,636,160 | 193,349 | 4,829,509 | -683,519 | |
| Q1 2022 | 4,594,757 | 1,045,072 | 5,639,829 | 573,034 | 3,793,145 | 4,366,179 | 1,273,650 | |
| Q2 2022 | 12,369,850 | 5,544,804 | 17,914,654 | 4,837,016 | 3,621,129 | 8,458,145 | 9,456,509 | |
| Q3 2022 | 992,997 | 42,055 | 1,035,052 | 4,330,757 | 3,264 | 4,334,021 | -3,298,969 | |
| Q4 2022 | 4,825,637 | 1,900,880 | 6,726,517 | 2,663,644 | 0 | 2,663,644 | 4,062,873 | |
| Q1 2023 | 911,736 | 1,209,511 | 2,121,247 | 309,116 | 0 | 309,116 | 1,812,131 | |
| Q2 2023 | 234,765 | 46,269,399 | 46,504,164 | 3,614,008 | 0 | 3,614,008 | 42,890,156 | |
| Q3 2023 | — | 6,139,639 | 0 | 6,139,639 | -6,139,639 | |||
| Q4 2023 | — | — | 0 | |||||
| Q1 2024 | 0 | 737,000 | 737,000 | — | 737,000 | |||